首页>
外国专利>
Expression Levels of COL4A3BP and other Markers Correlating with Progression or Non-Progression of Bladder Cancer
Expression Levels of COL4A3BP and other Markers Correlating with Progression or Non-Progression of Bladder Cancer
展开▼
机译:COL4A3BP和其他与膀胱癌进展或未进展相关的标志物的表达水平
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed is determining expression levels of protective or harmful markers for bladder cancer prognosis; particularly, determining the expression level of COL4A3BP alone or in combination with expression levels of MBNL2, FABP4, and NEK1 or other markers where increased expression levels of these protective markers relative to a control correlates with lack of bladder cancer progression and decreased expression levels correlate with bladder cancer progression or death. Also disclosed particularly is determining the expression level of COL4A1 alone or in combination with expression levels of UBE2C, BIRC5, COL18A1, KPNA2, MSN, ACTA2, and CDC25B or other markers where increased expression levels of these harmful markers relative to a control correlates with bladder cancer progression or death and decreased expression levels correlate with lack of bladder cancer progression. Also disclosed are signatures of protective and harmful markers to predict likelihood of bladder cancer progression or non-progression.
展开▼